DRUG RECALLS: APRIL 2011 

 

APRIL 2011: BEST ENHANCER RECALLED DUE TO UNDECLARED DRUG INGREDIENT CALLED SULFOAILDENAFIL, AN ANALOGUE OF SILDENAFIL AN FDA APPROVED DRUG USED IN THE TREAMENT OF ERECTILE DYSFUNCTION (ED) MAKING THESE PRODUCTS UNAPPROVED DRUGS.

APRIL 2011: BENZOCAINE TOPICAL PRODUCTS- SPRAYS, GELS AND LIQUIDS RECALLED DUE TO RISK OF METHEMOGLOBINEMIA A SERIOUS AND POTENTIALLY FATAL ADVERSE EFFECT (serious condition in which the amount of oxygen carried through the blood stream is greatly reduced) ASSOCIATED WITH BENZOCAINE PRODUCTS THAT ARE USED DURING MEDICAL PROCEDURES SUCH AS NUMBING THE MUCOUS MEMBRANES OF THE MOUTH AND THROAT, ALSO OVER THE COUNTER BENZOCAINE GELS AND LIQUIDS USED TO RELIEVE PAIN SUCH AS TEETHING, CANKER SORES, ETC.

APRIL 2011: BENICAR (OLMESARTAN) IS STILL NOT CONSIDERED TO BE SAFE TO TREAT HIGH BLOOD PRESSURE. BENICAR IS NOT RECOMMENDED TO AS A TREATMENT TO DELAY OR PREVENT PROTEIN IN THE URINE (MICROALBUMINURIA) IN DIABETIC PATIENTS.

APRIL 2011: 2 LOTS OF TOPAMAX (TOPIRAMATE) 100MG TABLETS RECALLED DUE TO MUSTY ODOR THOUGHT TO BE CAUSED BY TRACE AMOUNTS OF TBA (2,4,6 TRIBROMOANISOLE). WHILE NOT CONSIDERED TO BE TOXIC, TBA CAN GENERATE AN OFFENSIVE ODOR AND A SMALL NUMBER OF PATIENTS HAVE REPORTED TEMPORARY GASTROINTESTINAL SYMPTOMS. THERE HAVE NOT BEEN NO SERIOUS ADVERSE EVENTS REPORTS.